Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Germ Cell Tumor 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × sabarubicin × Clear all
NCT00027781 2012-07-24

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003982 2012-07-11

MEN-10755 in Treating Patients With Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
30 enrolled
Genitourinary

Testicular Germ Cell Tumor, Endodermal Sinus Tumor

NCT00003028 2012-07-02

MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
5 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡